Inamed’s Board Embraces Allergan’s Offer After Dissolving Deal With Medicis
Inamed's board unanimously approved a proposed plan to merge with Allergan for $3.2 bil. on Dec. 15, two days after rejecting Medicis' $2.8 bil. acquisition offer
Inamed's board unanimously approved a proposed plan to merge with Allergan for $3.2 bil. on Dec. 15, two days after rejecting Medicis' $2.8 bil. acquisition offer